SI
RGNX icon

Sofinnova Investments’s Regenxbio RGNX Stock Holding History

Sofinnova Investments’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-213,959
Closed -$5.66M – 63
2022
Q3 		$5.66M Sell
213,959
-562,665
-72% -$16.7M 0.33% 43
2022
Q2 		$19.2M Buy
776,624
+162,539
+26% +$4.06M 1.6% 17
2022
Q1 		$20.4M Sell
614,085
-393,996
-39% -$10.9M 1.55% 15
2021
Q4 		$33M Buy
1,008,081
+880,488
+690% +$30M 1.93% 12
2021
Q3 		$5.35M Sell
127,593
-300,147
-70% -$10.8M 0.32% 53
2021
Q2 		$16.6M Buy
427,740
+66,005
+18% +$2.36M 0.96% 29
2021
Q1 		$12.3M Buy
361,735
+90,621
+33% +$3.86M 0.74% 30
2020
Q4 		$12.3M Buy
271,114
+211,607
+356% +$7.39M 0.73% 28
2020
Q3 		$1.64M Buy
+59,507
New +$1.94M 0.12% 64

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return